Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, today announced that the U.S. Food and Drug ...

Crinetics (CRNX) announced that the European Medicines Agency has validated the marketing authorization application for paltusotine, the first ...

Apitegromab is an investigational treatment aimed at improving motor function for people living with spinal muscular atrophy. Scholar Rock said it has also submitted and received validation for its ...

Dr. Reddy’s Laboratories (RDY) and Alvotech (ALVO) announced that the U.S. FDA has accepted a Biologic License Application submission for AVT03. Read more here.

The FDA has set a PDUFA target action date of October 23, 2025, for the low-dose atropine formulation.

CVs and/or application requests sent via email will not be answered ... Occasionally, some roles may still require candidates to apply by completing a Personal History Form (PHF) word document and ...

Integra won’t be clear of the lingering impacts of the Boston facility issues for at least another year (depending upon the timing of the PriMatrix and SurgiMend facility transfers), but I think ...

paving the way for SurgiMend and PriMatrix production to resume. ResMed reported a second-quarter fiscal 2025 adjusted EPS of $2.43, which topped the Zacks Consensus Estimate by 5.6%. Revenues of ...

It's easy to integrate data from multiple sources, not least from Google Sheets and Forms, Excel from Microsoft ... This includes basic application and automation features and connects to ...